STRO - Why Virios Therapeutics Shares Are Trading Lower By Around 48%? Here Are Other Stocks Moving In Monday's Mid-Day Session | Benzinga
Shares of Virios Therapeutics, Inc. (NASDAQ:VIRI) fell sharply during Monday's session after the company priced a $1.7 million public offering of 8.5 million shares of common stock at $0.20 per share.
Virios Therapeutics shares dipped 47.6% to $0.1850 on Monday.
Here are some other stocks moving in today’s mid-day session.
Gainers
- MultiMetaVerse Holdings Limited (NASDAQ:MMV) shares jumped 224% to $2.01. MultiMetaVerse Holdings signed a non-binding term sheet to acquire 100% of Bowong Technology (Shenzhen) Co., Ltd. and its subsidiaries.
- GT Biopharma, Inc. (NASDAQ:GTBP) rose 146% to $7.64. GT Biopharma, last week, posted a narrower-than-expected quarterly loss.
- Tantech Holdings Ltd (NASDAQ:TANH) jumped 89.8% to $1.2501.
- Faraday Future Intelligent Electric Inc. (NASDAQ:FFIE) shares gained 62.1% to $1.6701. Faraday Future Intelligent Electric is scheduled to report its fourth quarter and full year 2023 results after the closing bell on Tuesday, May 28.
- CN Energy Group. Inc. (NASDAQ:CNEY) surged 58% to $1.0501.
- Scorpius Holdings, Inc. (NASDAQ:SCPX) gained 57.8% to $0.1635. Scorpius, last week, announced closing of public offering.
- NKGen Biotech, Inc. (NASDAQ:NKGN) rose 46% to $1.6250 after the company’s SNK01 NK Cell Therapy was cleared to begin a Phase 2 trial in Alzheimer’s disease.
- Bruush Oral Care Inc. (NASDAQ:BRSH) jumped 41% to $0.1658.
- Rekor Systems, Inc. (NASDAQ:REKR) gained 36% to $1.80 after the company announced a partnership with MS2.
- MIRA Pharmaceuticals, Inc. (NASDAQ:MIRA) gained 34.3% to $0.8866 after the company said it has advanced new preclinical studies using Ketamir-2 towards clinical development.
- Scilex Holding Company (NASDAQ:SCLX) gained 34% to $1.21.
- Hims & Hers Health, Inc. ...